InvestorsHub Logo
Followers 2
Posts 183
Boards Moderated 0
Alias Born 07/01/2009

Re: None

Saturday, 08/22/2009 5:29:28 PM

Saturday, August 22, 2009 5:29:28 PM

Post# of 15122
Please spread this information to new investors. It is very interesting stuff. Guys this is the next HTDS. Good company. .01 here we come. WE NEED TO SPREAD THESE FACTS TO NEW INVESTORS! THIS INFORMATION IS HARD TO FIND!


************
Guys, do not sell this at the bid! We are going to filthy rich. Load
the boat this will hit .01+ soon!
********

Ok guys something serious could be going on with OPGX. Check out what
i am going to share with you- credit goes to bankshot at investorshub.

Quote:
Quote:
"Except for its investments in Optigenex Inc. and in Symphony ViDA,
Inc., the Company does not own or control, directly or indirectly, any
interest in any corporation, partnership, limited liability
partnership, limited liability company, association or other entity."

Hmmm, this is from an 8K filing by Oxigene, a NASDAQ company, on July
15, 2009.
http://www.sec.gov/Archives/edgar/da...34oiexv1w1.htm
Quote:
Quote:
In Oxigene's 10Q, filed for period 6/30/09, there isn't any mention of
Optigenex but there is of Symphony ViDA which they also mentioned in
the 8K filed 7/15/09...wonder if that means they invested in OPGX
after the 6/30 date...hmmm...still searching. I don't know what type
investments they'd make with DOMS around, lol...

Marketable securities held by Symphony ViDA, Inc., restricted 12,626
14,663

http://www.sec.gov/Archives/edgar/da...235oie10vq.htm
Quote:
Quote:
"I don't know what type investments they'd make with DOMS around,
lol..."

Maybe preferred shares?

Still looking...
Quote:
Interesting...possibly...Oxigene is acquiring Symphony Vida {July 6
PR}...

Quoted from below:
"OXiGENE is dedicated to leveraging its intellectual property and
therapeutic development expertise to bring life-extending and life-
enhancing medicines to patients."

OXiGENE Announces Agreement to Acquire Symphony ViDA, Including More
Than $12 Million in Unrestricted Cash and All Rights to OXi4503 and
ZYBRESTAT for Ophthalmology
Quote:
Quote:
"OXiGENE, Inc. (Nasdaq:OXGN) (Stockholm:OXGN), a clinical-stage
biopharmaceutical company developing novel therapeutics to treat
cancer and eye diseases, announced that the Company..."

-----[]-----

Dec 21, 2007 12:08 ET

Young Canadian Entrepreneur Tackles Cancer Epidemic With AGEOFF®

TORONTO, ONTARIO--(Marketwire - Dec. 21, 2007) -

Attention health, lifestyle and environmental editors.

AGEOFF, a safe new clinically proven anti-ageing NutriCosmetic pill
designed to re-activate internal health and external beauty, will make
its first appearance live on the Shopping Channel on January 11, 2008.

"For those who want to feel great, look younger and proactively
protect themselves from pre-mature ageing and disease, AGEOFF® is the
answer," says Ryan Foley, Inventor of AGEOFF and President of NuvoCare
Health Sciences. "AGEOFF evolved from my genuine interest in
proactively tackling the cancer epidemic Canadians are facing. I spent
the last 8 years of my life dedicated to studying this growing
phenomenon. The results of my research were nothing short of amazing
and showed that AGEOFF addressed the primary cause of cancer - DNA
mutation. What was also interesting to note from this research was
that AGEOFF also had a unique side-effect - It helped subject's look
and feel biologically younger!"

http://www.marketwire.com/press-rele...nc-805764.html

-----[]-----

I wonder...if...they have found a cancer fighting property in "our
ac-11"? Could it be? Na, too good to be true...
Could OPGX be bought out?
source: http://www.hotstockmarket.com/forums...05#post2134405
****************
Guys i also just called investors relation. Here is the #2013552098.
Leave a message and they will call you. They called me after 15
minutes. I asked him a few questions. He said the business was doing
very good - but he can't give me any details. They have already made a
few sales in turkey and that they are expecting a press release soon -
he wouldn't tell me when but he said it should be within 30 days. Also
he said they are working on a new website should be up and running in
30 days. He said, "We are a small company and we have a very good
product. There is a reason why the biggest pharmacy companys in the
world are doing business with us. Our product is the best and is the
latest trend. It is safe."
****************
Why OPGX?
Guys I am expecting the summer is almost over. Early fall 2009 is a
few weeks away! Fall semester starts August 24th! I am predicting a
press release for the launch of commercial sales very soon. This
company has a unique patented product. Check out the article from
biomedreports.com I have the link on the bottom.
************
Optigenex Inc. Announces Rollout of Activar(R) AC-11(R) Oral
Supplements and Activar(R) AC-11(R) Next Generation Skin Care Products
in Turkey Through Its Middle Eastern Distribution Partner Ekson Farma,
Istanbul
Company Expects Commercial Sales to Begin in Early Fall 2009 Through
Pharmacies and Other Healthcare Distribution Channels
All-natural, and standardized at a minimum of 8 per cent Carboxy Alkyl
Esters ("CAEs(TM)"), AC-11® is the only patented aqueous extract of
the Uncaria species that can make the following therapeutic claims
("DNA repair, Immune enhancement and Inhibition of pro-inflammatory
agents") which are validated by a broad spectrum of scientific and
clinical studies.
AC-11® already has gained a major foothold in Japan and has been
introduced in other select territories of Asia as a branded ingredient
used by over 100 manufacturers and distributors in a variety of anti-
aging cosmetic, cosmeceutical and dietary supplement products. With
their regional alliance together, Optigenex and Middle Eastern based
Ekson Farma anticipate similar market penetration, growth and
expansion for AC-11®
We believe our alliance with Optigenex provides us with the
opportunity to introduce Turkey and the Middle East to the next major
brand in oral and topical applications."
Source:
http://biomedreports.com/articles/new-latest-news/3260-optigenex-inc-...